Streetbeat News

Price Targets

WH

Truist Securities analyst Patrick Scholes has maintained a 'Buy' rating on Wyndham Hotels & Resorts (NYSE:WH) but lowered the price target from $96 to $95.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 2:36 pm

UCBI

Truist Securities analyst Jennifer Demba maintains a 'Hold' rating on United Community Banks (NASDAQ:UCBI) and raises the price target from $27 to $30.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 2:35 pm

TSLA

Truist Securities analyst William Stein maintains a 'Hold' rating on Tesla (NASDAQ:TSLA) and raises the price target from $240 to $254.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 2:34 pm

RLJ

Truist Securities analyst Gregory Miller has maintained a 'Buy' rating on RLJ Lodging (NYSE:RLJ), but lowered the price target from $15 to $14.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 2:32 pm

PNFP

Truist Securities analyst Jennifer Demba maintains a 'Buy' rating on Pinnacle Financial Partners (NASDAQ:PNFP) and raises the price target from $61 to $73.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 2:31 pm

PK

Truist Securities analyst Patrick Scholes maintains a 'Buy' rating on Park Hotels & Resorts (NYSE:PK) but lowers the price target from $20 to $19.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 2:30 pm

VC

JP Morgan analyst Ryan Brinkman maintains a Neutral rating on Visteon (NASDAQ:VC) and raises the price target from $156 to $157.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 2:30 pm

MRK

Truist Securities analyst Robyn Karnauskas has maintained a 'Buy' rating on Merck & Co (NYSE:MRK), but lowered the price target from $118 to $116.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 2:30 pm

LEGN

Morgan Stanley has maintained an Overweight rating on Legend Biotech and raised its price target from $65 to $85. This has resulted in Legend Biotech's shares trading higher.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 2:29 pm

HPK

Truist Securities analyst Neal Dingmann maintains a 'Sell' rating on HighPeak Energy (NASDAQ:HPK) and raises the price target from $6 to $8.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 2:28 pm